Entero Healthcare Solutions IPO Day 3: Check GMP, subscription status, review, key dates, and other details

livemint.com:

₹8 crore, and a discount of ₹119 per equity share is being offered to eligible employees bidding in the employee reservation portion. Entero Healthcare Solutions IPO raised ₹716 crore from 25 anchor investors at the upper price band of ₹1,258 per equity share. On the last day of subscription, the Entero Healthcare Solutions IPO was subscribed only 1.53 times.

The IPO received 1,09,49,884 shares against offered 71,50,100 shares, as per data by BSE. Healthcare IPO retail investors portion was subscribed 1.33 times, Non Institutional Investors (NII) portion was booked 0.22, and Qualified Institutional Buyers (QIB) portion was booked 2.28 times. The employee portion was subscribed 1.25 times.

Entero Healthcare Solutions IPO, which is worth ₹1,600 crore, comprises a fresh issue of ₹1000 crore, and an offer-for-sale (OFS) of up to 4,769,475 equity shares by the promoters and other investors aggregating up to ₹600 crore. The promoters selling shareholders are Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited. The biggest shareholder to sell is OrbiMed Asia III Mauritius Limited, which is offloading 3,815,580 equity shares.

Prabhat Agrawal and Prem Sethi will sell 470,210 and 313,472 equity shares, respectively. Additional shareholders that are selling their shares include Novacare Drug Specialities Private Limited, which is selling up to 42,250 equity shares, and K.E. Prakash, who is selling up to 39,610 equity shares.